关注
John Kim
John Kim
CHA Medical University
在 chamc.co.kr 的电子邮件经过验证
标题
引用次数
引用次数
年份
Externalizing and attentional behaviors in children of depressed mothers treated with a selective serotonin reuptake inhibitor antidepressant during pregnancy
TF Oberlander, P Reebye, S Misri, M Papsdorf, J Kim, RE Grunau
Archives of pediatrics & adolescent medicine 161 (1), 22-29, 2007
2522007
Stereoselective disposition of fluoxetine and norfluoxetine during pregnancy and breast‐feeding
J Kim, KW Riggs, S Misri, N Kent, TF Oberlander, RE Grunau, C Fitzgerald, ...
British journal of clinical pharmacology 61 (2), 155-163, 2006
1622006
Pharmacokinetics of a ginseng saponin metabolite compound K in rats
IB Paek, Y Moon, J Kim, HY Ji, SA Kim, DH Sohn, JB Kim, HS Lee
Biopharmaceutics & drug disposition 27 (1), 39-45, 2006
1292006
Paroxetine levels in postpartum depressed women, breast milk, and infant serum
S Misri, J Kim, KW Riggs, X Kostaras
Journal of Clinical Psychiatry 61 (11), 828-832, 2000
1232000
Simultaneous determination of sildenafil and its active metabolite UK-103,320 in human plasma using liquid chromatography–tandem mass spectrometry
J Kim, HY Ji, SJ Kim, HW Lee, SS Lee, DS Kim, M Yoo, WB Kim, HS Lee
Journal of Pharmaceutical and biomedical Analysis 32 (2), 317-322, 2003
692003
Comparative Pharmacokinetics and Pharmacodynamics of a New Sustained-Release Growth Hormone (GH), LB03002, Versus Daily GH in Adults with GH …
M Bidlingmaier, J Kim, C Savoy, MJ Kim, N Ebrecht, S de la Motte, ...
The Journal of Clinical Endocrinology & Metabolism 91 (8), 2926-2930, 2006
642006
A randomized placebo-controlled, dose-finding study of oral LB80380 in HBeAg-positive patients with chronic hepatitis B
MF Yuen, J Kim, CR Kim, V Ngai, JCH Yuen, C Min, HM Kang, BS Shin, ...
Antiviral therapy 11 (8), 977-984, 2006
592006
Antiviral activity and safety of LB80380 in hepatitis B e antigen–positive chronic hepatitis B patients with lamivudine‐resistant disease
MF Yuen, KH Han, SH Um, SK Yoon, HR Kim, J Kim, CR Kim, CL Lai
Hepatology 51 (3), 767-776, 2010
532010
Potent and orally bioavailable 8-bicyclo [2.2. 2] octylxanthines as adenosine A1 receptor antagonists
WF Kiesman, J Zhao, PR Conlon, JE Dowling, RC Petter, F Lutterodt, ...
Journal of medicinal chemistry 49 (24), 7119-7131, 2006
512006
Stereoselective pharmacokinetics of fluoxetine and norfluoxetine enantiomers in pregnant sheep
J Kim, KW Riggs, DW Rurak
Drug metabolism and disposition 32 (2), 212-221, 2004
422004
Pharmacokinetics of LB80331 and LB80317 following oral administration of LB80380, a new antiviral agent for chronic hepatitis B (CHB), in healthy adult subjects, CHB patients …
MF Yuen, SH Lee, HM Kang, CR Kim, J Kim, V Ngai, CL Lai
Antimicrobial agents and chemotherapy 53 (5), 1779-1785, 2009
282009
Pharmacokinetics of lithospermic acid B isolated from Salvia miltiorrhiza in rats
H Hyun Kim, J Kim, H Young Ji, Y Chul Kim, D Hwan Sohn, B Mu Lee, ...
Journal of Toxicology and Environmental Health, Part A 68 (23-24), 2239-2247, 2005
242005
Oral bioavailability and enterohepatic recirculation of otilonium bromide in rats
BS Shin, JJ Kim, J Kim, SK Hu, HK Kim, HS Lee, SD Yoo
Archives of pharmacal research 31, 117-124, 2008
142008
Development of LC/MS/MS assay for the determination of 5-ethyl-2-{5-[4-(2-hydroxyethyl) piperazine-1-sulfonyl]-2-propoxyphenyl}-7-propyl-3, 5-dihydropyrrolo [3, 2-d] pyrimidin …
BS Shin, SK Hu, J Kim, JG Oh, WN Youn, B Lee, KA Um, DK Kim, JY Lee, ...
Journal of pharmaceutical and biomedical analysis 45 (1), 176-184, 2007
132007
Development of a liquid chromatography/electrospray tandem mass spectrometry assay for the quantification of apicidin, a novel histone deacetylase inhibitor, in rat serum …
BS Shin, J Kim, CH Yoon, CH Kim, EH Park, JW Han, SD Yoo
Rapid Communications in Mass Spectrometry: An International Journal Devoted …, 2005
132005
Pharmacokinetics of a novel histone deacetylase inhibitor, apicidin, in rats
BS Shin, HS Chang, EH Park, CH Yoon, HY Kim, J Kim, JK Ryu, OP Zee, ...
Biopharmaceutics & drug disposition 27 (2), 69-75, 2006
112006
Simultaneous determination of a new phosphodiesterase-5 inhibitor DA-8159 and its active metabolite in human plasma by high performance liquid chromatography with tandem mass …
J Kim, SJ Kim, HY Ji, JK Jin, SS Lee, DS Kim, M Yoo, WB Kim, HS Lee
Chromatographia 57, 447-450, 2003
112003
Stereoselective excretion of fluoxetine and norfluoxetine in breast milk and neonatal exposure
J Kim, S Misri, KW Riggs, DM Ryan, D Carter, DW Rurak
1997 Annual Meeting New Research Program and Abstracts. Washington, DC …, 1997
111997
Phase II multi-centre, dose-escalating study of LB80380 (ANA380) in hepatitis B patients with lamivudine-resistant YMDD mutant HBV
CL Lai, KH Han, SK Yoon, SH Um, MF Yuen, HS Kim, HR Kim, HC Chung, ...
Journal of Hepatology, 2006
102006
Interim report for a phase II, multi-centre, dose-escalating study of LB80380/ANA380 in hepatitis B patients with lamivudine-resistant YMDD mutant HBV
CL Lai, KH Han, SK Yoon, SH Um, MF Yuen, HS Kim, HR Kim, HC Chung, ...
Journal of Hepatology, 2005
82005
系统目前无法执行此操作,请稍后再试。
文章 1–20